Skip to main content

The rockefeller university

News & HighlightsNews
Financial crashes, pandemics, Texas snow: How math could predict "black swan" events
Statistical modeling may one day help scientists anticipate and manage a wide range of extreme occurrences, according to a new study.
An old antibiotic may combat drug-resistant tuberculosis
Drug-resistant strains of tuberculosis bacteria affect half a million people a year. A compound first discovered in the 1980s may be able to help.
Why male mosquitoes leave humans alone
Unlike their female counterparts, male mosquitoes have no desire to bite us. But the hardware for host-seeking is hidden in the male mosquito brain, locked behind a simple genetic switch. 
This fish is about to flip 
An elaborate set of zebrafish experiments is shining light on one of neuroscience’s greatest enigmas: How brains make decisions. By tracking neural activity, scientists can now predict a fish’s next move before it happens.
Rockefeller grants commercial license for the development of monoclonal antibodies for treatment of COVID-19
The treatment, a combination of two antibodies, has been shown highly capable of neutralizing SARS-CoV-2 in preclinical studies. Researchers hope it will give countries around the world, including developing countries, a way to control the rampant disease.
COVID-19 vaccines may need regular updates for emerging variants
Lab experiments suggest that the new strains reported in Britain, South Africa, and Brazil may blunt the potency of the Pfizer and Moderna COVID-19 vaccines. This could mean that the vaccines will need updates as the virus mutates.
Neurophysiologist Victor Wilson, 92, has died
Victor Wilson, a neurophysiologist who traced the intricate neural mechanisms that govern our balance and posture, died on January 20 at the age of 92.
Synthetic “micro lungs” could take COVID-19 research to the next level
Scientists have developed stem-cell technology to mass-produce tissue cultures resembling our breathing organs. These tissues offer a powerful model in which to study how SARS-CoV-2 wreaks havoc in the lungs and to screen for new drugs.
The immune system mounts a lasting defense after recovery from COVID-19
The study participants continued to improve their antibodies months after initial infection, potentially due to exposure to remnants of the virus hidden in the gut.
The blood may hold clues to some of COVID-19’s most mysterious symptoms
COVID-19 causes a host of diverse complications, from lung inflammation to blood clots, heart failure, and brain fog. A team of scientists believes these attributes may have a single culprit—and that findings from research on Alzheimer’s disease might give them a leg up in finding it.
Rockefeller begins testing of new COVID-19 antibody drug in people
Patients in the clinical trial will receive two highly potent antibodies against SARS-CoV-2 discovered at the university. Designed to prevent people with early COVID-19 from developing severe disease, the treatment is urgently needed as hospitals continue to be inundated by repeated surges of inf...
What Darwin never guessed 
Scientists have found that evolution isn’t always a one-way street toward specialization.
Scientists capture the moving parts of the portal to the cell’s nucleus
The proteins of the nuclear pore complex flip-flop rapidly between two orientations as they let cargo through.
Study of 50,000 people finds brown fat may protect against many diseases
People with brown fat tissue tend to burn calories more quickly, but do they also enjoy better health? Now the largest study of its kind shows that brown fat is indeed linked to reduced risk of heart disease, type 2 diabetes, and several other conditions.
Llamas immune to coronavirus, what zebrafish are thinking, and other memorable science stories of 2020 
This year's scientific endeavors included multiple attacks on SARS-CoV-2—and a lot more. Here are the most memorable science stories to come out of Rockefeller labs, from cracking the code behind specific skin cancer subtypes to understanding what goes on inside a fish brain.
As COVID-19 vaccines emerge, the search for antiviral drugs continues
Scientists are digging through drug libraries of 430,000 compounds, in pursuit of an antiviral drug that can stop the novel coronavirus in its tracks.
A mediocre mutator 
Scientists developed a method to safely examine the ability of SARS-CoV-2 to escape future drugs or vaccines by mutating. Their initial results are reassuring.
Royalty Pharma and Pablo and Almudena Legorreta Support Development of Antibody-Based COVID-19 Therapy at The Rockefeller University
Royalty Pharma and The Rockefeller University announced generous gifts totaling $5,760,000 from Royalty Pharma and Pablo and Almudena Legorreta.
Scientists map the network of SARS-CoV-2’s helpers inside human cells
The virus must hijack a more than a hundred human proteins to replicate inside a cell. One of them stands out because it is an absolute requirement for infection by four different coronaviruses as well as by viruses that cause Zika, yellow fever, and other diseases.
Charles M. Rice formally receives 2020 Nobel Prize in a virtual ceremony
Rice was honored for research that contributed to a cure for hepatitis C. He accepted the Nobel medal and diploma at the Swedish Consulate in New York City.
Marina Caskey is promoted to professor of clinical investigation
Caskey, a clinician in the lab of Michel Nussenzweig, has spent the last decade working on clinical studies of experimental immune-based vaccines and therapies.
New five-year fundraising campaign has already received $200 million in gifts
The $675 million Campaign for the Convergence of Science and Medicine, launched July 1, 2019, aims to fulfill the priorities identified in the university’s 2020-2024 strategic plan.
What bats can teach us about COVID-19
Unlike most humans, bats are naturally resistant to coronavirus infection. Researchers are now searching their genomes for clues that might explain why SARS-CoV-2 can cause devastating disease in our own species.
Telomere shortening protects against cancer
Researchers have found the first evidence that telomere shortening is not just a sign of aging, but a key component of the body's cancer prevention system.
Some cells are multilingual 
Experiments in zebrafish are shining light onto a poorly understood process in which cells communicate mechanically, by pushing and pulling on each other.
Conservation of resources is hardwired into the genetic code
A study of marine microbes reveals that conservation of nutrients is a fundamental property of cells in all living organisms, from plants to humans.
New atlas reveals the journey of human cells throughout development
The largest map of gene expression in over 4 million human cells charts the dynamic path to forming different organs.
Science fights back 
Researchers have launched a tremendous race to understand the new virus and attack it from every angle. How they work and collaborate might never again be the same.
Primordial shapeshifters 
Only in sci-fi movies can a living cell be created from scratch. But a recent discovery suggests that this tantalizing feat might one day become possible in the real world.
How the immune system deals with the gut's plethora of microbes
New research suggests that our immune system may play an active role in shaping the digestive-tract flora, which is tightly linked to health and disease.
View
View